Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Tumor-Agnostic 1Thoracic 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 19Mycosis Fungoides 7Lymphoma, T-Cell, Peripheral 7Lymphoma 6Lymphoma, Large-Cell, Anaplastic 5Sezary Syndrome 4Lymphoma, T-Cell 4Hodgkin Disease 4Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Waldenstrom Macroglobulinemia 2Melanoma 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Immunoblastic Lymphadenopathy 2Burkitt Lymphoma 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma, Extranodal NK-T-Cell 1

Interventions

pembrolizumab 40Nivolumab 18trametinib 13Cyclophosphamide 13dabrafenib 11Vemurafenib 10Interleukin-2 10Ipilimumab 9fludarabine 7Docetaxel 7fludarabine phosphate 6cemiplimab 6Paclitaxel 6Cisplatin 6Carboplatin 6atezolizumab 5Radiotherapy 5Drug Therapy 5Dacarbazine 5Blood Specimen Collection 5Biopsy 5poly ICLC 4binimetinib 4Therapeutics 4Psychiatric Rehabilitation 4sotigalimab 3montanide ISA 51 3encorafenib 3cobimetinib 3budigalimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × romidepsin × Dermatologic × Clear all
NCT01445340 2019-12-17

Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
6 enrolled
DermatologicLymphoid

Mycosis Fungoides, Neoplasms, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡